{
    "N/R/U": null,
    "Applicant": "Aimmune Therapeutics, Inc.",
    "BLA Number": "125757",
    "Proprietary Name": "Vowst",
    "Proper Name": "fecal microbiota spores, live-brpk",
    "BLA Type": "351(a)",
    "Strength": "1X10 LOG 6 AND 3X10 LOG 7CFU/TAB",
    "Dosage Form": "Capsule",
    "Route of Administration": "Oral",
    "Product Presentation": "Bottle",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "April 26, 2023",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2109",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "April 26, 2023",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "April 26, 2035",
    "Orphan Exclusivity Exp. Date": "April 26, 2030",
    "drug": [
        {
            "name": "fecal microbiota spores, live-brpk",
            "drugbank_id": "https://go.drugbank.com/drugs/DB17743"
        }
    ]
}